Sam: Improving Outcomes and Quality of Life in Atopic Dermatitis
0.25 AMA PRA Category 1 Credit(s) ™, 0.25 AANP Contact Hours
October 31, 2019
The accreditation for this activity has expired.
Primary Audience:
Primary Care Physicians, Nurse Practitioners, Physician Assistants
Relevant Terms:
Atopic Dermatitis
Brad P. Glick, DO, MPH, FAAD, FAOCD
Program Director, Dermatology Residency
Larkin Community Hospital Palm Springs
Deputy Chair, Individual Giving Committee, AAD
Vice President, Florida Society for Dermatology and Dermatologic Surgery
Clinical Assistant Professor of Dermatology
Herbert Wertheim College of Medicine
Miami, Florida
Dr. Brad Glick is a board certified dermatologist and dermatologic surgeon with clinical and academic practices in South Florida. He is the Director of the Dermatology Residency at the Larkin Hospital, Palm Springs and Clinical Assistant Professor of Dermatology at the Herbert Wertheim College of Medicine Miami, Florida. Dr. Glick is also Director, and Principal Investigator for GSI Clinical Research in Margate, Florida as well as the current Vice President for the Florida Society for Dermatology and Dermatologic Surgery.Dr. Glick’s Dermatology residency training was performed at the Greater Miami Skin and Laser Center at Mount Sinai Medical Center, Miami Beach, Florida where he earned certificates in Dermatologic, Mohs Micrographic, and Laser Surgery.
He is a Diplomate of the American Osteopathic Board of Dermatology, American Osteopathic Board of Family Practice, and National Board of Osteopathic Medical Examiners. Dr. Glick has also served as past President of the American Osteopathic College of Dermatology (AOCD), President of the Foundation for Osteopathic Dermatology (FOD), and past President of the Broward County Dermatologic Society.
Adelaide A. Hebert, MD
Professor of Dermatology and Pediatrics
UTHealth McGovern Medical School, Houston
Houston, TX
Dr. Hebert is Professor of Dermatology and Pediatrics at the University of Texas Health Science Center at Houston. She is also a Professor in the Section of Dermatology at the University of Texas M.D. Anderson Cancer Center. After earning a BS in microbiology at Louisiana State University and her MD degree from Tulane University, she completed an internship in Internal Medicine and a residency in Dermatology at the University of Texas Medical Branch in Galveston, followed by a Pediatric Dermatology fellowship at Northwestern University in Chicago.
Clinical research has been one of Dr. Hebert’s interests during her tenure at the University of Texas Health Sciences Center at Houston. She has been involved in a wide array of research arenas with special focus on atopic dermatitis, psoriasis, hyperhidrosis, tuberous sclerosis and neurofibromatosis. Other areas of research interest have included skin and soft tissue infections, acne, wounds including pyoderma gangrenosa, fungal infections of the skin, scalp and nails, herpes simplex and herpes zoster infections, diaper dermatitis, lupus erythematosus, rosacea, actinic keratosis, contact dermatitis, disorders of keratinization and multiple sclerosis.
Dr. Hebert is board certified in Dermatology, Pediatric Dermatology and Wound Healing. Dr. Hebert was President of the Society for Pediatric Dermatology in 2006–2007 and served on the Board of Directors for ten years. She served as the first Chair of the Society for Pediatric Dermatology Foundation. She is a board member and co-founder of the International Hyperhidrosis Society. Dr. Hebert served as President of the Women’s Dermatologic Society during 2016-2017 and was elected to the American Academy of Dermatology’s Board of Directors in 2018.
Paul Yamauchi, MD, FAAD
Paul Yamauchi, MD, FAAD
Clinical Assistant Professor of Dermatology
David Geffen School of Medicine
University of California
Los Angeles, CA
Dr. Yamauchi is a dermatologist in private practice and medical director at both the Dermatology Institute & Skin Care Center and Clinical Science Institute in Santa Monica, California. He has admitting privileges and is on staff at St. John’s Hospital in Santa Monica and the UCLA Medical Center. Dr. Yamauchi is a clinical assistant professor of medicine in the Division of Dermatology at the David Geffen School of Medicine at UCLA and Harbor-UCLA Medical Center and Associate Professor at the John Wayne Cancer Institute in Santa Monica, CA. He specializes in medical and complex dermatology, dermatologic surgery, aesthetic dermatology, and clinical research.
Dr. Yamauchi is a fellow with the American Academy of Dermatology, the American Academy of Cosmetic Surgery, the American Society of Dermatology Surgery, the American Society of Laser Medicine and Surgery, the Pacific Dermatology Association and the Los Angeles Metropolitan Dermatologic Society. He serves on the editorial board of various journals and on task force committees for the American Academy of Dermatology. He is the author or co-author of more than 70 publications, including several books. Dr. Yamauchi has edited a book entitled “Biologic and Systemic Agents in Dermatology” and is editor-in-chief of Dermatology Reports.
Dr. Yamauchi is recognized as a key opinion leader in psoriasis and atopic dermatitis and was previously on the Medical Board for the National Psoriasis Foundation and is currently on the Scientific Advisory Council for the National Eczema Association. He has extensive experience using the new biologics in the treatment of psoriasis and atopic dermatitis, and has been invited as a speaker at international, national, regional, and local venues to talk about new advances in the treatment of psoriasis and atopic dermatitis. In addition, he is strong advocate in establishing patient support groups for psoriasis. Dr. Yamauchi has published extensively in new advances in the treatment of psoriasis and atopic dermatitis.
ACCME ACCREDITATION STATEMENT
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Albert Einstein College of Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AANP ACCREDITATION STATEMENT
National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 0.25 contact hours of continuing education.
PROGRAM OVERVIEW
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by intense itching and recurrent eczematous lesions. The disease affects up to 20% of children and up to 3% of adults. AD usually starts in childhood, and may represent the cutaneous manifestation of an “atopic march” in which most patients also develop asthma and allergic rhinitis.
AD has a tremendous negative impact on the quality of life of both patients and their families. The disease is associated with several comorbidities, including mental health disorders (depression, anxiety, autism, ADHD), hypertension, obesity, infections, osteoporosis, fractures, vitiligo, alopecia areata, visual problems, and dental issues. Patients are more accident-prone, sleep disturbances are common, and persist even during periods of remission.
This online curriculum will examine the clinical characteristics, the current immuno-pathophysiology, and the psychosocial and quality of life impact of AD on patients across age groups, and provide strategies to individualize treatment for patients with atopic dermatitis.
FINANCIAL ACKNOWLEDGEMENT
This activity is supported by an educational grant from Pfizer Inc.
FACULTY DISCLOSURE POLICY
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities.
The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relationship with a commercial interest*. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.
Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
The staff of the Center for Continuing Professional Development has no relevant conflicts of interest with any ACCME-defined commercial interest.
*The ACCME defines a commercial interest as an entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by or used on patients. The ACCME does not consider providing clinical service directly to patients to be commercial interests - unless the provider of the clinical service is owned, or controlled by, an ACCME-defined commercial interest.
FACULTY DISCLOSURES
Brad Glick, DO has disclosed the following relevant financial relationships:
Advisor for AbbVie, Celgene, Dermavant, Dermira, Lilly, Novartis, Ortho Dermatologics, Pfizer, Sanofi Genzyme, and Sun Pharma
Investigator for AbbVie, Celgene, ChemoCentryx, Dermira, and Sun Pharma
Speakers' Bureau for AbbVie, Celgene, Dermira, Lilly, Novartis, Ortho Dermatologics, Pfizer, and Sun Pharma
Adelaide Hebert, MD has disclosed the following relevant financial relationships:
Consulting fees received from Cutanea, Demira, Galderma, Menari, Ortho, and UCB
Data and Safety Monitoring Board for Bausch, GlaxoSmithKline, and Sanofi Regeneron
Principal Investigator for Brickell, Cutanea, Demira, Pfizer, and Novan
Speakers’ Bureau for Almirall, Cutanea, Menarini, Ortho, and Pfizer
Paul Yamauchi, MD has disclosed the following relevant financial relationships:
Consulting fees received from Lilly, Regeneron, and Sanofi
Principal Investigator for AbbVie, Amgen, Botanix, Galapagos, Genentech, Glenmark, Incyte, Kiniska, Leo, Lilly, Pfizer, Regeneron, and Vanda
Speakers’ Bureau for Regeneron, Sanofi, and Pfizer
INDEPENDENT PEER REVIEWER
Ranon E. Mann, MD
Assistant Professor of Medicine (Dermatology)
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, NY
CME REVIEWER
Victor B. Hatcher, PhD
Associate Dean for Continuing Professional Development
Albert Einstein College of Medicine
Director, Center for Continuing Professional Development
Montefiore Medical Center
Bronx, NY
Victor B. Hatcher, PhD has no relevant conflicts of interest with any ACCME-defined commercial interest.
Josh Kilbridge, Medical Writer
PLANNING COMMITTEE DISCLOSURES
Gregg Sherman, MD, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.
Josh Kilbridge, Medical Writer, has no relevant conflicts of interest with any ACCME-defined commercial interest.
Michelle Frisch, MPH, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.
Sandy Bihlmeyer, MEd, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.
HOW TO CLAIM CREDIT
- Read the learning objectives and faculty disclosures.
- Participate in the activity.
- Complete the post-test and activity evaluation.
- Physicians who successfully complete the post-test and evaluation will receive CME credit.
- Nurse Practitioners who successfully complete the post-test and evaluation will receive AANP CE credit.
- You must score 70% or higher on the post-test to receive credit for this activity.
- All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
COURSE FORMAT/MEDIUM: Internet Activity Enduring Material
ESTIMATED TIME TO COMPLETE THE ACTIVITY: 15 min
DISCLAIMER
The opinions expressed during the educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine or the National Association for Continuing Education.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
PRIVACY
Albert Einstein College of Medicine and Montefiore Medical Center, Center for Continuing Professional Development (Einstein) protects the privacy of personal and other information regarding participants and educational collaborators. Einstein will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting to the ACCME.
Einstein maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information collected from you.
Additional information regarding Albert Einstein College of Medicine's Privacy Policy can be viewed at https://www.mecme.org/PrivacyStatement.aspx
SUPPORTED BROWSERS:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above
For video playback, install the latest version of Flash or Quicktime.
SUPPORTED PHONES & TABLETS:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
